CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion

Allal Ouhtit*, Mohammed E. Abdraboh, Andrew D. Hollenbach, Hatem Zayed, Madhwa H.G. Raj

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Background: We have previously validated three novel CD44-downstream positively regulated transcriptional targets, including Cortactin, Survivin and TGF-β2, and further characterized the players underlying their separate signaling pathways. In the present study, we identified CD146 as a potential novel target, negatively regulated by CD44. While the exact function of CD146 in breast cancer (BC) is not completely understood, substantial evidence from our work and others support the hypothesis that CD146 is a suppressor of breast tumor progression. Methods: Therefore, using molecular and pharmacological approaches both in vitro and in breast tissues of human samples, the present study validated CD146 as a novel target of CD44-signaling suppressed during BC progression. Results: Our results revealed that CD44 activation could cause a substantial decrease of CD146 expression with an equally notable converse effect upon CD44-siRNA inhibition. More interestingly, activation of CD44 decreased cellular CD146 and increased soluble CD146 through CD44-dependent activation of MMP. Conclusion: Here, we provide a possible mechanism by which CD146 suppresses BC progression as a target of CD44-downstream signaling, regulating neovascularization and cancer cell motility.

Original languageEnglish
Article number45
JournalCell Communication and Signaling
Issue number1
Publication statusPublished - Nov 9 2017
Externally publishedYes


  • Breast cancer
  • CD146
  • CD44
  • MMPs
  • Metastasis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion'. Together they form a unique fingerprint.

Cite this